EHAB
Enhabit, Inc.
Medical - Care Facilities
Market Cap$706M
5Y Perf.-40.0%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
EHAB vs SEM
Revenue, margins, valuation, and 5-year total return — side by side.
SEM
Select Medical Holdings Corporation
Medical - Care Facilities
Market Cap$2.04B
5Y Perf.+29.2%
EHAB vs SEM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | EHAB | SEM |
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $706M | $2.04B |
| Revenue (TTM) | $1.06B | $5.52B |
| Net Income (TTM) | $-3M | $134M |
| Gross Margin | 34.5% | 10.6% |
| Operating Margin | 7.2% | 5.8% |
| Forward P/E | 22.8x | 13.1x |
| Total Debt | $500M | $3.70B |
| Cash & Equiv. | $44M | $27M |
EHAB vs SEM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
EHAB
SEM
| Stock | Jun 22 | May 26 | Return |
|---|---|---|---|
| Enhabit, Inc. (EHAB) | 100 | 60.0 | -40.0% |
| Select Medical Hold… (SEM) | 100 | 129.2 | +29.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EHAB vs SEM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: SEM leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Enhabit, Inc. is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
EHAB
Enhabit, Inc.
The Income Pick
EHAB is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.44
- Rev growth 2.4%, EPS growth 97.1%, 3Y rev CAGR -0.3%
- Lower volatility, beta 0.44, Low D/E 88.6%, current ratio 1.63x
Best for: income & stability and growth exposure
SEM
Select Medical Holdings Corporation
The Long-Run Compounder
SEM carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 158.5% 10Y total return vs EHAB's -44.9%
- 5.1% revenue growth vs EHAB's 2.4%
- Lower P/E (13.1x vs 22.8x)
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | SEM | 5.1% revenue growth vs EHAB's 2.4% |
| Value | SEM | Lower P/E (13.1x vs 22.8x) |
| Quality / Margins | SEM | 2.4% margin vs EHAB's -0.3% |
| Stability / Safety | EHAB | Beta 0.44 vs SEM's 0.46, lower leverage |
| Dividends | SEM | 1.5% yield; the other pay no meaningful dividend |
| Momentum (1Y) | EHAB | +68.0% vs SEM's +11.1% |
| Efficiency (ROA) | SEM | 2.3% ROA vs EHAB's -0.3%, ROIC 4.8% vs 4.5% |
EHAB vs SEM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
EHAB vs SEM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLSEMLAGGINGEHAB
EHABEnhabit, Inc.
2leads
SEMSelect Medical Holdin…
3leads
6 Total Categories
CATEGORYLEADERvs EHABMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
EHAB4/6
Valuation MetricsMultiples, price ratios, and targets
SEM5/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
SEM5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
SEM4/6
Risk & VolatilityBeta, volatility, and downside exposure
EHAB2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
EHAB leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SEM is the larger business by revenue, generating $5.5B annually — 5.2x EHAB's $1.1B. Profitability is closely matched — net margins range from 2.4% (SEM) to -0.3% (EHAB). On growth, SEM holds the edge at +5.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | EHABEnhabit, Inc. | SEMSelect Medical Ho… |
|---|---|---|
| RevenueTrailing 12 months | $1.1B | $5.5B |
| EBITDAEarnings before interest/tax | $98M | $465M |
| Net IncomeAfter-tax profit | -$3M | $134M |
| Free Cash FlowCash after capex | $81M | $117M |
| Gross MarginGross profit ÷ Revenue | +34.5% | +10.6% |
| Operating MarginEBIT ÷ Revenue | +7.2% | +5.8% |
| Net MarginNet income ÷ Revenue | -0.3% | +2.4% |
| FCF MarginFCF ÷ Revenue | +7.6% | +2.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.9% | +5.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.9% | -18.2% |
EHAB leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
SEM leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, SEM's 12.0x EV/EBITDA is more attractive than EHAB's 13.5x.
| Metric | EHABEnhabit, Inc. | SEMSelect Medical Ho… |
|---|---|---|
| Market CapShares × price | $706M | $2.0B |
| Enterprise ValueMkt cap + debt − cash | $1.2B | $5.7B |
| Trailing P/EPrice ÷ TTM EPS | -152.10x | 13.93x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.84x | 13.06x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 13.47x | 12.04x |
| Price / SalesMarket cap ÷ Revenue | 0.67x | 0.37x |
| Price / BookPrice ÷ Book value/share | 1.24x | 1.00x |
| Price / FCFMarket cap ÷ FCF | 10.73x | 5.33x |
SEM leads this category, winning 5 of 6 comparable metrics.
Profitability & Efficiency
SEM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SEM delivers a 6.6% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-1 for EHAB. EHAB carries lower financial leverage with a 0.89x debt-to-equity ratio, signaling a more conservative balance sheet compared to SEM's 1.82x. On the Piotroski fundamental quality scale (0–9), EHAB scores 6/9 vs SEM's 5/9, reflecting solid financial health.
| Metric | EHABEnhabit, Inc. | SEMSelect Medical Ho… |
|---|---|---|
| ROE (TTM)Return on equity | -0.6% | +6.6% |
| ROA (TTM)Return on assets | -0.3% | +2.3% |
| ROICReturn on invested capital | +4.5% | +4.8% |
| ROCEReturn on capital employed | +6.0% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.89x | 1.82x |
| Net DebtTotal debt minus cash | $456M | $3.7B |
| Cash & Equiv.Liquid assets | $44M | $27M |
| Total DebtShort + long-term debt | $500M | $3.7B |
| Interest CoverageEBIT ÷ Interest expense | 0.83x | 4.41x |
SEM leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
SEM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SEM five years ago would be worth $8,886 today (with dividends reinvested), compared to $5,512 for EHAB. Over the past 12 months, EHAB leads with a +68.0% total return vs SEM's +11.1%. The 3-year compound annual growth rate (CAGR) favors SEM at 2.4% vs EHAB's 0.7% — a key indicator of consistent wealth creation.
| Metric | EHABEnhabit, Inc. | SEMSelect Medical Ho… |
|---|---|---|
| YTD ReturnYear-to-date | +51.6% | +11.4% |
| 1-Year ReturnPast 12 months | +68.0% | +11.1% |
| 3-Year ReturnCumulative with dividends | +2.1% | +7.4% |
| 5-Year ReturnCumulative with dividends | -44.9% | -11.1% |
| 10-Year ReturnCumulative with dividends | -44.9% | +158.5% |
| CAGR (3Y)Annualised 3-year return | +0.7% | +2.4% |
SEM leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
EHAB leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
EHAB is the less volatile stock with a 0.44 beta — it tends to amplify market swings less than SEM's 0.46 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | EHABEnhabit, Inc. | SEMSelect Medical Ho… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.44x | 0.46x |
| 52-Week HighHighest price in past year | $14.22 | $16.99 |
| 52-Week LowLowest price in past year | $6.47 | $11.65 |
| % of 52W HighCurrent price vs 52-week peak | +96.9% | +96.8% |
| RSI (14)Momentum oscillator 0–100 | 58.6 | 60.9 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 2.1M |
EHAB leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates EHAB as "Hold" and SEM as "Hold". Consensus price targets imply 9.5% upside for SEM (target: $18) vs -1.8% for EHAB (target: $14). SEM is the only dividend payer here at 1.55% yield — a key consideration for income-focused portfolios.
| Metric | EHABEnhabit, Inc. | SEMSelect Medical Ho… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $13.53 | $18.00 |
| # AnalystsCovering analysts | 11 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | +1.5% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | — | $0.25 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.9% |
Insufficient data to determine a leader in this category.
Key Takeaway
SEM leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). EHAB leads in 2 (Income & Cash Flow, Risk & Volatility).
Best OverallSelect Medical Holdings Cor… (SEM)Leads 3 of 6 categories
Loading custom metrics...
EHAB vs SEM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is EHAB or SEM a better buy right now?
For growth investors, Select Medical Holdings Corporation (SEM) is the stronger pick with 5.
1% revenue growth year-over-year, versus 2. 4% for Enhabit, Inc. (EHAB). Select Medical Holdings Corporation (SEM) offers the better valuation at 13. 9x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate Enhabit, Inc. (EHAB) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EHAB or SEM?
On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13.
1x.
03Which is the better long-term investment — EHAB or SEM?
Over the past 5 years, Select Medical Holdings Corporation (SEM) delivered a total return of -11.
1%, compared to -44. 9% for Enhabit, Inc. (EHAB). Over 10 years, the gap is even starker: SEM returned +158. 5% versus EHAB's -44. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EHAB or SEM?
By beta (market sensitivity over 5 years), Enhabit, Inc.
(EHAB) is the lower-risk stock at 0. 44β versus Select Medical Holdings Corporation's 0. 46β — meaning SEM is approximately 4% more volatile than EHAB relative to the S&P 500. On balance sheet safety, Enhabit, Inc. (EHAB) carries a lower debt/equity ratio of 89% versus 182% for Select Medical Holdings Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — EHAB or SEM?
By revenue growth (latest reported year), Select Medical Holdings Corporation (SEM) is pulling ahead at 5.
1% versus 2. 4% for Enhabit, Inc. (EHAB). On earnings-per-share growth, the picture is similar: Enhabit, Inc. grew EPS 97. 1% year-over-year, compared to -28. 9% for Select Medical Holdings Corporation. Over a 3-year CAGR, EHAB leads at -0. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EHAB or SEM?
Select Medical Holdings Corporation (SEM) is the more profitable company, earning 2.
7% net margin versus -0. 4% for Enhabit, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SEM leads at 6. 1% versus 6. 0% for EHAB. At the gross margin level — before operating expenses — EHAB leads at 46. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EHAB or SEM more undervalued right now?
On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13.
1x forward P/E versus 22. 8x for Enhabit, Inc. — 9. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SEM: 9. 5% to $18. 00.
08Which pays a better dividend — EHAB or SEM?
In this comparison, SEM (1.
5% yield) pays a dividend. EHAB does not pay a meaningful dividend and should not be held primarily for income.
09Is EHAB or SEM better for a retirement portfolio?
For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
46), 1. 5% yield, +158. 5% 10Y return). Both have compounded well over 10 years (SEM: +158. 5%, EHAB: -44. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EHAB and SEM?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EHAB is a small-cap quality compounder stock; SEM is a small-cap deep-value stock. SEM pays a dividend while EHAB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(EHAB: 1.9% · SEM: 5.0%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.